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ABSTRACT
Aim: The aim of our study was to compare the function and volumes of kidneys
of very low birth-weight (VLBW) and of extremely low birth-weight (ELBW) infants at
pre-school ages.
Patients and methods: We did a revision of the neonatal records of infants born in
our hospital that weighed £1500 g at birth. The children were divided into two groups
according to their weight at birth: ELBW (<1000 g) and VLBW (1000–1500 g). At the
age of 5.7 ± 1.4 years, the children underwent clinical, laboratory and ultrasound renal
assessments.
Results: Sixty-nine children fulfilled the requirements for the study. The rate of neo-
natal treatment with aminoglycosides was higher in ELBW preterms. Renal function param-
eters, i.e. estimated glomerular filtration rate and albuminuria, did not differ between the
two groups of children. Urinary a1-microglobulin excretion was significantly higher and
kidneys were significantly smaller in the ELBW group than in the VLBW group.
Conclusion: No impairment or differences in renal parameters were found in pre-school
children born ELBW compared with those born with VLBW, except for differences in kidney volume,
renal cortical thickness and urinary a1-microglobulin excretion. Thus, patients born with ELBW
would require a longer follow-up period.
INTRODUCTION
Low birth weight (LBW) has been associated with an
increased risk of hypertension, cardiovascular events and
impaired renal function in adulthood (1,2). However, the
causal pathways of this association are poorly understood.
Because nephrogenesis continues for up to 40 days after
premature birth, pre-terms are at risk of kidney damage
from postnatal nephrotoxic medication and malnourish-
ment (3). Moreover, the remaining nephrons may undergo
hyperfiltration and glomerulosclerosis (3,4).
Over the past two decades, extremely low birth weight
(ELBW) infants have experienced a better survival rate
because of the improved quality of neonatal care. Observa-
tional studies have shown that very premature babies have
an increased risk of hypertension in adulthood (5). More-
over, children born pre-term seem to run higher overall
risks of kidney problems than children born at-term (6).
Therefore, recent investigations disagree on altered renal
function and kidney size in school-aged children and young
adults born prematurely and of LBW (7–9).
No studies have compared very low birth weight (VLBW)
and ELBW categories of children born preterm. As differ-
ences between the two categories could reveal different
renal prognoses, the aim of this report was to compare the
function and volumes of kidneys of VLBW and ELBW




We reviewed 170 records of newborns born alive in our
hospital between January 2000 and December 2004 that
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weighed £1500 g at birth. Of the 170 potential initial
patients, 73 patients could not be contacted because of
incorrect addresses and phone numbers. The other 97
patients were invited to participate in the study. Of these,
one had died and 27 declined to participate. In the end, the
parents of 69 babies agreed to participate in the study and
all the patients’ parents gave written informed consent to
perform analyses on their children. The Ethics Committee
of our hospital approved the study protocol (Prot. N.
2430 ⁄ CE of 02 ⁄ 10 ⁄ 2008).
The children were divided into two groups according to
their weight at birth: extremely low birth-weight
(ELBW < 1000 g at birth) and very low birth-weight
(VLBW 1000–1500 g at birth). Small for gestational age
(SGA) was defined as a birth weight under the -2 standard
deviations, i.e. below the gender-specific 2.5th centile for
gestational age, for normal foetal growth (10). We revised
the at-birth charts of each preterm for creatinine levels and
urinary output. According to the pRIFLE criteria, acute kid-
ney injury (AKI) in the neonatal period is defined as a 50%
decrease in creatinine clearance and reduced urinary output
– 0.5 mL ⁄ kg ⁄ h over 16 h (11).
We compared kidney function parameters and volumes
of ELBW and VLBW children. All the babies were born in
the Verona city hospital (Neonatal Intensive Care Unit);
they had no chromosomal anomalies, congenital infections
or urogenital malformations. During pregnancy, the moth-
ers had not taken any medication known to influence kid-
ney development in the foetus. Gestational age, birth
weight, laboratory data (serum creatinine), postnatal drug
administration (ibuprofen ⁄ indomethacin and ⁄ or gentami-
cin ⁄ amikacin) and prenatal ultrasounds were reviewed
from the medical records of each patient. The children par-
ticipating in the study were not taking any medication at the
time of enrolment in the study.
We revisited the NICU charts for clinical data at birth of
the children not contacted, of those who refused and of
those who participated in the study. No statistical differ-
ences (chi-square test) were found between the enrolled (69
total) and missed patients (101) for the sex ratio (50.7% vs.
54.3% males), gestational age (29.2 ± 2.7 vs. 29.2 ± 2.9
weeks) and birth weight (1121 ± 289 vs. 1104 ± 299 g).
Moreover, we found no differences for neonatal adminis-
tration of NSAIDs (non-steroidal anti-inflammatory drugs;
17.4% vs. 18.1%) or aminogycosides (gestamicin ⁄ amikacin;
63.8% vs. 60.6%). Finally, we found no differences in the
rate of AKI (10.3% vs. 8.8%), respiratory distress syndrome
(63.8% vs. 67%), bronchopulmonary dysplasia (18.8% vs.
13.8%), sepsis (13% vs. 12.8%) or necrotizing enterocolitis
(1.4% vs. 4.3%) after birth. No data concerning current
therapies and unresolved physical complications were avai-
lable for the missed children.
Clinical evaluation
The children underwent clinical assessments, measurement
of growth parameters and blood pressure by the same medi-
cal investigators (MB, RM) when they were 5.7 ± 1.4 years
old. Height was measured to the nearest 0.5 cm on a
standardized, wall-mounted height board. Weight was
determined to the nearest 0.1 kg on a standard physician’s
beam scale with the child dressed in light underwear and no
shoes. Body mass index (BMI) was calculated by dividing
weight (kg) by height squared (m2). Body surface area (BSA,
m2) was calculated according to the Dubois formula (12).
Systolic and diastolic BP were recorded as ‘casual’ sitting
measurements using the automated Dinamap oscillometric
technique according to the Fourth Task Force on Pediatric
Hypertension (13). All clinical data were recorded (BF) on
an electronic database (Microsoft Office Excel 2003).
Laboratory tests on renal function
Blood samples collected mid-morning (around 09:00–
10:00 am) were stored in EDTA-coated tubes and immedi-
ately analysed in the laboratory of the Verona hospital
(GG). In particular, creatinine was measured using a modi-
fied Jaffé reaction to improve assay accuracy by eliminating
the non specific contribution of plasma proteins and biliru-
bin interference (14). Cystatin C was measured by immuno-
nephelometry using a latex particle-coated method with
specific antibodies to Cystatin C (15). We also measured
blood electrolytes (calcium, magnesium, sodium and potas-
sium), urea, uric acid and acid–base equilibrium (pH, bicar-
bonate and base excess). Samples of aldosterone and renin
hormones were collected after a minimum of 2 h in a stand-
ing position and then again later after 10 min in a seated
position (16).
Urine samples were collected during the morning by ran-
dom spontaneous voiding. In urine, we assessed pH, gravity,
a1-microglobulin (normal value for age <12 mg ⁄ L,
<1.71 mg ⁄ mmol creatinine), electrolytes (sodium, potas-
sium and calcium), uric acid and proteins, following stan-
dard laboratory methods.
The estimated glomerular filtration rate (eGFR) was cal-
culated according to Schwartz’s formulas (17). In particu-
lar, we used both the serum creatinine based equation and
the serum creatinine ⁄ cystatin-C ⁄ BUN based equation to
calculate the eGFR of our LBW children. These formulas
are the most updated ones to calculate the eGFR, although
they were not tested on children with GFR over 90, which is
a limitation to this study.
Ultrasound assessment of renal parameters
Ultrasound assessment of kidney size and volume enables
early recognition of either pathological growth or hypopla-
sia (18). Renal measurements were taken with the children
in a supine position, scanning from the para-coronal angle
with the transducer positioned to obtain the longest kidney
length. The ultrasound probe was placed on the back of the
child only when the presence of abdominal gases precluded
adequate scanning from the standard position. For each
child examined, kidney length, width and thickness were
calculated as the average of three consecutive measure-
ments by the same investigator (CB). The investigator (CB)
was not aware of the birth weight category of each patient.
Kidney volume was calculated using the echo machine soft-
ware. Ultrasound was performed using a convex transducer
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(frequent 4 MHz probe) on a digital last-generation scanner
(Sequoia Systems; Acuson, Mountain View, CA, USA). Kid-
ney volume was calculated using the ellipsoid formula
(length · width · thickness · p ⁄ 6). The parenchymal thick-
ness was measured as the distance between the capsule and
the margin of the sinus echo; the measurement was taken in
the middle third of the kidney. Each child underwent Dopp-
ler ultrasound assessment of intrarenal arteries (CB). Resis-
tive index (RI) was calculated as (peak systolic frequency
shift – peak diastolic frequency shift) ⁄ peak systolic fre-
quency shift (19).
Statistical analysis
The VLBW and ELBW subjects were analysed statistically
by comparing categorical variables by means of the chi-
square or Fisher exact test, while the Mann–Whitney test
was used to compare continuous, not normally distributed
variables. Data are reported as median and 95% confidence
interval (CI). Bonferroni correction was applied for multiple
comparisons. The Spearman correlation test was used to
verify correlations between variables. Multivariate analysis
was carried out by means of the logistic binary regression
analysis model, using the birth weight categories (VLBW or
ELBW) as the dependent variables and the VLBWs as the
reference group. The variables inserted in this model were
age, sex, height, total renal volume, urinary a1-microglobu-
lin, eGFR Schwart’s complex formula, administration of
aminoglucosides and administration of NSIADs. For the
selection of predictive variables, we used the backward step-
ping of variables and evaluation of the model using a good-
ness-of-fit chi-square statistics. Pressigned p-values > 0.05
controlled the stepping removal. The odd ratio (OR), 95%
CI and p values are reported for variables with significance.
Statistical analysis was performed using the SPSS 17.0 pro-
gram for Windows (SPSS Inc, Chicago, IL, USA).
RESULTS
Study population
The total number of children that fulfilled the requirements
for the study was 69 (50.7% males), 22 of which were twins
(31.9%). Gestational age (GA, as mean ± standard devia-
tion) at birth was 29.2 ± 2.7 weeks and birth weight was
1122 ± 277 g. Forty-three children were born with a VLBW
and 26 children were born with an ELBW; 27.9% and
30.8% were born SGA respectively (chi-square test
p = 0.993). All the children were Caucasians (Italian).
During hospitalization in the Neonatal Intensive Care
Unit, the children born of ELBW showed umbilical and
inguinal hernias (one baby), C. albicans sepsis (one baby)
and patent foramen ovale (two babies). Moreover, ELBW
newborns required mechanical ventilation and had umbili-
cal artery catheterization. Children born of VLBW showed
umbilical and ⁄ or inguinal hernias (two infants), interven-
tricular heart defect (one infant), patent foramen ovale (two
infants) and Listeria spp. sepsis and convulsions (one baby).
All the children were free of chromosomal anomalies and
urogenital malformations.
A comparison between the characteristics of the VLBW
and ELBW children at birth and at examination are summa-
rized in Table 1. Body mass index (BMI) at examination
was significantly lower in the ELBW group than in the
VLBW group (20). Body surface area (BSA, Dubois for-
mula) was comparable between the two categories of birth-
weight. Postnatal exposure to relevant medication included
ibuprofen or indomethacin (NSAIDs, 17.4%) and gentami-
cin or amikacin (aminoglycosides, 65.2%). ELBW infants
were more significantly treated with aminoglycosides
and ⁄ or NSAIDs than the VLBWs. Systolic and diastolic
blood pressures and did not differ between the two birth-
weight categories.
Renal function
In all infants, at examination, plasma creatinine concentra-
tion (as mean ± standard deviation) was 0.41 ± 0.08
mg ⁄ dL, plasma cystatin C was 0.36 ± 0.09 mg ⁄ L, estimated
values of glomerular filtration rate (eGFR) using Schwartz’s
formula were 114.3 ± 18.4 mL ⁄ min ⁄ 1.73 m2 for the creati-
nine-based equation and 97.2 ± 10.9 mL ⁄ min ⁄ 1.73 m2 for
the creatinine ⁄ cystatin-C ⁄ BUN based equation. In our pop-
ulation Pearson’s correlation coefficient between Sch-
wartz’s two eGFR formulas was 0.848 (p < 0.0001).
Serum creatinine, cystatin C, eGFR and plasma renin
activity did not differ between the two groups of children.
Urinary a1-microglobulin was significantly higher in the
ELBW group than in the VLBW group (Table 1). However,
both serum biochemical (calcium, phosphorus, magnesium,
BUN, uric acid, pH venous, bicarbonate, base excess,
plasma renin activity, aldosterone to renin activity ratio)
and urinary parameters (fractional excretion of sodium,
potassium and uric acid, calcium ⁄ creatinine ratio and
protein ⁄ creatinine ratio) were comparable between the two
groups. However, a comparison of all the babies who
received post-natal aminoglycosides (45 did) versus
those who did not (24) showed statistically significantly
higher a1-microglobulin excretion (Mann–Whitney test,
p = 0.013). Applying Bonferroni’s correction, a1-microglob-
ulin was falsely statistically significantly different between
the two groups. Moreover, VLBW infants who received
post-natal aminoglycosides (20 did), compared with those
who did not (23), showed statistically significantly higher
a1-microglobulin excretion (p = 0.032). A comparison
among ELBW infants was not performed because too few
subjects did not receive neonatal aminoglycosides to make
possible a statistical analysis (25 did versus 1).
Kidney volume
Total kidney volume at examination (as mean ± standard
deviation) was 84.5 ± 20.1 cm3. Table 2 shows the results
of the measurements of right, left and total kidney volumes
for the VLBW and ELBW children. Kidney size (length, left
cortical thickness and volume) was significantly lower in
the ELBW children than in the VLBWs. Right cortical
thickness was comparable between VLBWs and ELBWs.
Similarly, the resistive index (RI) was comparable between
VLBWs and ELBWs. Therefore, in VLBWs the right renal
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thickness was significantly less and the right RI significantly
higher than in the left kidney. In ELBWs, renal thickness
and RI were comparable between kidneys.
A comparison of all the babies who received post-natal
aminoglycosides (45 did) versus those who did not (24)
showed comparable total renal volume (p = 0.209). More-
over, VLBW infants who received post-natal aminoglyco-
sides (20 did), compared with those who did not (22),
showed comparable total renal volume (p = 0.326). A
comparison among ELBW infants was not performed
because too few subjects did not receive neonatal amino-
glycosides to make possible a statistical analysis.
With the Spearman test, birth weight gave positive signifi-
cant correlation with total renal volume, BMI, systolic BP
and negative significant correlation with urinary a1-micro-
globulin excretion at follow-up (Table 3). Birth weight cor-
related positively, but with borderline significance
(p = 0.05), with Schwartz’s eGFR complex formula.
Table 1 Comparison of the characteristics [showed as median and 95% confidence interval (CI)] of healthy children born of extremely low birth weight (ELBW)
and of very low birth weight (VLBW)
VLBW ELBW v2 test (p-value)
Number 43 26 –
Twins (n) 13 9 0.452
Gender (males ⁄ females) 25 ⁄ 18 10 ⁄ 16 0.091
NSAID (n, Yes ⁄ No) 3 ⁄ 40 9 ⁄ 17 0.006
Aminoglycoside (n, Yes ⁄ No) 20 ⁄ 23 25 ⁄ 1 <0.001
AKI (n, Yes ⁄ No) 4 ⁄ 38 3 ⁄ 23 0.546
Median (95% CI) Median (95% CI) Mann–Whitney test (p-value)
Gestational age (weeks) 30.1 (29.9–31.3) 27.0 (26.3–27.7) <0.001
Birth weight (g) 1,315 (1,248–1,352) 850 (775–883) <0.001
Age at follow-up (years) 5.4 (5.2–6.1) 5.3 (5.2–6.3) 0.848
BSA (m2) 0.77 (0.75–0.83) 0.73 (0.70–0.79) 0.181
BMI (kg ⁄ m2) 16.0 (15.7–17.0) 14.2 (14.0–15.9 <0.001
Systolic BP (mmHg) 105 (103–110) 102 (97–111) 0.121
Diastolic BP (mmHg) 62 (59.9–65.1) 60 (56.4–65.4) 0.314
Creatinine (mg ⁄ dL) 0.41 (0.39–0.43) 0.42 (0.38–0.45) 0.860
Cystatin-C (mg ⁄ L) 0.62 (0.60–0.66) 0.67 (0.61–0.69) 0.262
Schwartz’s eGFR (mL ⁄ min ⁄ 1.73 m2)* 114 (110–120) 109 (105–122) 0.603
Schwartz’s eGFR (mL ⁄ min ⁄ 1.73 m2)† 96 (95–101) 94.5 (91–101) 0.298
a1-microglobulin (mg ⁄ L) 0.00 (0.53–2.31) 2.65 (1.96–5.03) 0.017
a 1-microglobulin ⁄ creatinine (mg ⁄ mmol) 0.00 (0.05–0.25) 0.16 (0.25–0.79) 0.008
Aminoglycoside = gentamicin or amikacin, AKI = acute kidney injury, BMI = body mass index, BP = blood pressure, BSA = body surface area (Dubois formula),
NSAID = ibuprofen or indomethacin.
*eGFR by Schwartz creatinine based equation.
†eGFR by Schwartz creatinine ⁄ cystatin-C ⁄ BUN based equation.
Bold values highlight the statistically significant differences.
Table 2 Comparison of renal ultrasound parameters [showed as median and 95% confidence interval (CI)] between healthy children born of very low birth weight
(VLBW) and of extremely low birth weight (ELBW)
Ultrasound parameters VLBW children, median (95% CI) ELBW children, median (95% CI) Mann–Whitney test (p-value)
Right kidney
Length (cm) 7.28 (7.15–7.71) 7.00 (6.68–7.21) 0.037
Cortical thickness (cm) 1.00 (0.89–1.02)* 1.00 (0.89–1.02)§ 0.934
Volume (cm3) 43.0 (40.7–48.2)† 34.0 (32.9–40.4)¶ 0.008
Resistive index 0.67 (0.65–0.68)‡ 0.69 (0.65–0.71)** 0.376
Left kidney
Length (cm) 7.52 (7.35–7.75) 7.18 (6.74–7.30) 0.004
Cortical thickness (cm) 1.20 (1.11–1.29) 1.00 (0.96–1.10) <0.001
Volume (cm3) 44.4 (42.7–49.6) 37.8 (34.1–42.2) 0.008
Resistive index 0.64 (0.62–0.67) 0.67 (0.64–0.69) 0.281
Right and left kidneys
Total volume (cm3) 86.3 (84.1–97.1) 73.8 (69.0–80.7) 0.002
Right volume (% contribution) 49.4 (47.1–50.6) 47.4 (45.5–52.7) 0.696
Right kidney versus left in VLBW: *p < 0.001, †p = 0.433, ‡p = 0.043
Right kidney versus left in ELBW: §p = 0.073, ¶p = 0.438, **p = 0.191.
Bold values highlight the statistically significant differences.
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Schwartz’s eGFR simplified, plasma renin activity (PRA),
aldosterone to renin activity ratio (ARR), fractional excre-
tion (FE, %) of sodium, potassium and urea and diastolic
BP did not correlate with birth weight.
Binary logistic regression analysis of the ELBW and
VLBW categories computed age, sex, height and urinary
a1-microglobulin, Schwart’s eGFR complex formula, total
renal volume, and administration of aminoglycosides
and ⁄ or NSAIDs. The analysis revealed that variables that
predicted inclusion in the ELBW category were neonatal
administration of aminoglycosides (OR = 30, 95% CI =
3.14–287; p = 0.003) and NSIADs (OR = 6.38, 95% CI =
1.02–39.9; p = 0.048) and the reduced renal dimensions at
follow-up (OR = 0.918, 95% CI = 0.87–0.97; p = 0.002).
Estimated renal function, microalbuminurias and a1-micro-
globulin excretion were excluded from the model.
DISCUSSION
Several investigations seem to disagree with renal dysfunc-
tion in individuals born with a VLBW. In particular, eGFR,
albumin excretion and kidney size measured using ultra-
sound in VLBW infants were all normal at 8 years of age
(21). However, mean percentiles for kidney length and vol-
ume, determined using ultrasound, and eGFR were compa-
rable with controls in children aged 6–12 years who were
born extremely premature (7). Other studies reported that
renal dimensions correlated significantly with birth-weight
(9), but the finding of loss of kidney mass was not a prognos-
tic indicator of deteriorating renal function in individuals born
ELBW (22). Moreover, very prematurely born individuals
and SGA showed minimal differences in kidney size and
function than controls at the age of 20 years (8,23). Thus,
these findings in human studies did not support the hypoth-
esis that prematurity contributes to the alteration of renal
function in childhood or even in young adulthood (8,9).
Other studies have reported that LBW may be associated
with abnormal kidney development and malfunction in
adulthood (24,25). Circumstantial evidence obtained from
animal and human studies supported that low nephron
quantity in adult born IUGR increased the risk of kidney
damage and renal pathology (26). In particular, kidneys of
LBW rats showed glomerular hypertrophy and an
increased risk of developing renal sclerosis (24). Accord-
ingly, autoptic studies in newborns and children have
reported a marked association between LBW and a
reduced number of nephrons (27). Moreover, VLBW
infants with postnatal acute renal failure showed low glo-
merular supply and clear evidence of active glomeruloscle-
rosis (28). When the number of nephrons is reduced, the
compensatory hypertrophy causes the glomeruli to function
under increased intracapillary hydraulic pressure, which,
over time, causes damage to the capillary walls. Recently,
five adult patients born under 1500 g and at less than
30 weeks of gestational age showed glomerulomegaly, seg-
mental glomerular sclerosis and proteinuria (29). Thus, in
humans, VLBW and prematurity have been linked to low
glomerular numbers, high glomerular size and progressive
susceptibility to renal disease in adulthood (6,29) because
of the pathological development of secondary glomerulo-
sclerosis (29).
We compared VLBW and ELBW infants (using VLBW
infants as the reference subjects) to detect differences in
renal function and dimensions among them, increasing
the evidence reported in the previous literature
(5,7–9,17,22,23,30). Our study did not reveal significant dif-
ferences in eGFR, using the new Schwartz formulas (17),
between children born with ELBW and VLBW, in agree-
ment with the previous findings (21). Moreover, in our
study, VLBW and ELBW infants had a comparable protein
excretion rate. In agreement, the previous investigations
reported no differences for microalbuminuria between
AGA and SGA, and between VLBW and LBW infants
(5,30). Instead, in young adults the prevalence of microalbu-
minuria in SGA was 3.8%, 2.4 times higher than that of
AGA subjects (23). Thus, longer follow-up is required for
our patients to detect signs of glomerular dysfunction
with age.
In our study, total renal volume and left cortical thickness
were smaller in our 5- to 6-year-old children born with
ELBW than with VLBW, contrary to the findings reported
elsewhere that were normal or minimal (7,8,23). However,
we found higher values of urinary a1-microglobulin in
babies born with ELBW than with VLBW; the former were
more frequently treated with aminoglycosides, although
none had values over the limits of normal range. However,
ELBW infants showed smaller kidneys at follow-up. In
short, reduced renal volume may be associated with low
birth weight, and the increased urinary a1-microglobulin
may be associated with neonatal administration of amino-
glycosides. Such findings may not be good prognostic signs
in infants born with ELBW. As the nephrotoxic action of
aminoglycosides on renal tubular function is greater in
patients born prematurely (30), follow-up of infants born







Total renal volume (cm3) 0.346 0.004
BMI (kg ⁄ m2) 0.248 0.040
a1-microglobulin (mg ⁄ L) )0.252 0.036
Systolic BP (mmHg) 0.298 0.020
eGFR Schwartz’s complex
formula (mL ⁄ min ⁄ 1.73 m2)
0.237 0.050
Not correlated
BSA (m2), age at follow-up, diastolic BP (mmHg), U-Protein ⁄ U-Creatinine
ratio (mg ⁄ mg), eGFR Schwartz’s simplified formula (mL ⁄ min ⁄ 1.73 m2), PRA
(ng ⁄ mL*h), ARR (ng ⁄ dL ⁄ ng ⁄ mL*h), U-calcium ⁄ creatinine ratio (mg ⁄ mg),
FE-Na (%), FE-K (%), FE-uric acid (%)
ARR = aldosterone to renin activity ratio, BP = blood pressure, BMI = body
mass index, BSA = body surface area, eGFR = estimated glomerular filtration
rate, FE = fractional excretion rate, PRA = plasma renin activity, RI = resistive
index, U = urinary.
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with ELBW is recommended to determine whether they
will show overt signs of tubular damage with age.
We report some limitations to the present preliminary
study. In particular, one bias could be the high number of
missed patients, the low number of patients enrolled, the
lack of comparison with normal controls and the inclusion
of babies that were SGA and AGA in the same LBW cate-
gory. Moreover, another bias could be the BP measurement
that was taken during a single visit.
In conclusion, no impairment or differences in renal
parameters were found in pre-school children born with
ELBW compared with VLBWs, except for differences in
kidney volume, left renal cortical thickness and urinary a1-
microglobulin excretion. These may not be good prognostic
signs. Thus, patients born with ELBW would require a
longer follow-up period.
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